GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of phase 2 — my 13-week log, condensed into one table — 21 comments in the full submission. View in context.
2.6k
c/retatrutide·submitted 2 months ago by u/deleted_my_history

phase 2 — my 13-week log, condensed into one table

Cautionbranch of 7 comments

Posting this because I searched for it and got nothing useful. Setup: 0.5mg, week 46, constipation present but not ruining anything. I changed exactly one variable — TRIUMPH — and tracked it for 17 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted it. So I am…

Read the full submission and all 21 comments →

This branch

7 comments, started 2 months ago
u/isabela_nilsen288 points·2 months ago

Mechanistically the bit that matters is TRIUMPH. It explains most of the early profile and a decent chunk of the outcome.

replysharereportpermalink
u/titration_marshalmod · c/semaglutide-24 points·2 months ago

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

replysharereportpermalink
u/careful_gradient_notes1 point·2 months ago

retatrutide is not approved anywhere for human use, posts must not read as instructions

replysharereportpermalink
u/ferran_krastev1 point·2 months ago

triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual

replysharereportpermalink
u/divya_bakken72 points·2 months ago

This is correct. Triple agonism is genuinely different.

replysharereportpermalink
u/hassan_nilsen50 points·2 months ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.